India to Cyprus: Posaconazole Export Trade Route

The India to Cyprus Posaconazole corridor is one of India's established pharmaceutical export routes, with 30 shipments documented worth a combined $9.7M USD. The route is dominated by AET LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 86% of all export value, reflecting the consolidated nature of India's posaconazole manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $324.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with posaconazole's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 22.2%, placing it at rank #17 among India's top posaconazole export destinations globally.

On the import side, key buyers of Indian posaconazole in Cyprus include DELORBIS PHARMACEUTICALS LTD, M/S. DELORBIS PHARMACEUTICALS LTD., DELORBIS PHARMACEUTICALS LIMITED and 5 others. DELORBIS PHARMACEUTICALS LTD is the single largest importer with 11 shipments valued at $4.2M USD.

India's posaconazole exports to Cyprus are driven primarily by a handful of large-scale manufacturers. AET LABORATORIES PRIVATE LIMITED with 27 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Cyprus benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AET LABORATORIES PRIVATE LIMITED, AET LABORATORIES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $324.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as posaconazole 100mg gr tablets and posaconazole 100mg gr tablets. batch no., suggesting that buyers in Cyprus tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, DELORBIS PHARMACEUTICALS LTD is the largest importer with 11 shipments worth $4.2M USD — representing 43% of all posaconazole imports from India on this route. A total of 8 buyers are active on this corridor.